CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 30 filers reported holding CATALYST BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,445 | +7.7% | 56,904 | -21.5% | 0.00% | – |
Q2 2023 | $25,475 | +34.2% | 72,453 | -21.0% | 0.00% | – |
Q1 2023 | $18,985 | +18.8% | 91,712 | +202.7% | 0.00% | – |
Q4 2022 | $15,984 | -99.2% | 30,301 | -90.1% | 0.00% | -100.0% |
Q4 2020 | $1,935,000 | +2550.7% | 306,690 | +4410.8% | 0.00% | – |
Q3 2018 | $73,000 | – | 6,799 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
BlackRock Inc. | 169,904 | $35,170 | 0.00% |
Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
Citadel Advisors | 5,700 | $1,180 | 0.00% |